Kimberly Steen

Program: Ph.D. Biomolecular Pharmacology/Pfizer
Advisor: Rachel Flynn, Ph.D.
Research Summary: Kimberly is interested in understanding the mechanism of pathogenesis in metabolic disease such as CKM (cardiovascular-kidney-metabolic syndrome), including discerning the metabolic microenvironment and how some pathological states persist over time even after intervention.